//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileHeaderAlt
by @jakesimonds.com
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...
Health economics, law, global health, and access to medicines. Economist @ MSF-USA but views my own. https://melissajbarber.github.io.
Melissa Barber
Loading...
Doctors Without Borders calls Gilead ‘unconscionable’ for refusing to sell HIV prevention drug to organization.. statnews.com/pharmalot/20... #pharma #HIV #AIDS #pharma #Gilead
10h
I've walked thru the economic logic here, but Gilead obviously does not say this out loud. They don't really have a good reason not to sell to MSF, which is why they landed on negotiating supply contracts is "a lot of work" (actual thing they said). 13/ www.doctorswithoutborders.org/latest/preve...
15h
The move came after months of talks in which Doctors Without Borders asked Gilead Sciences for a “limited” supply of lenacapavir.
Doctors Without Borders calls Gilead 'unconscionable' for refusing to sell HIV prevention drug to organization
statnews.com
MSF calls on Gilead for direct access to lenacapavir, as the current rollout falls far short of the needs.
www.doctorswithoutborders.org
Open letter to Gilead: Prevention should not be a privilege
Melissa Barber